Category: Science Blog November 14, 2014
We’ve launched three exciting crowdfunding projects with our researchers. Will they receive the money they need? Only you can decide.
Category: Science Blog October 24, 2014
Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?
Category: Science Blog October 22, 2014
Our scientists have shown for the first time how lymph nodes swell during infection, producing some striking images along the way.
Category: Science Blog October 21, 2014
Our latest funding scheme focuses on the emerging field of biotherapeutics – smarter cancer treatments based on cells and biological molecules.
Category: Science Blog October 14, 2014
Our scientists have found that melanoma cells follow the ‘trail’ of a naturally-occurring molecule in the body, encouraging them to spread.